Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on ESURE GROUP PLC. We currently have 3 research reports from 1 professional analysts.
|22Mar17 13:54||RNS||Director/PDMR Shareholding|
|22Mar17 13:53||RNS||Director/PDMR Shareholding|
|10Mar17 07:00||RNS||2016 Preliminary results|
|06Mar17 11:19||RNS||Directorate Change|
|01Mar17 07:00||RNS||Total Voting Rights|
|27Feb17 07:46||RNS||Comment on Ogden discount rate|
|22Feb17 08:45||RNS||Holding(s) in Company|
Frequency of research reports
Research reports on
ESURE GROUP PLC
ESURE GROUP PLC
14 Sep 16
"Bumpier seas are being anticipated for international equity markets between now and the year end. Two months of absolute calm, with daily moves of less than 1%, looks likely to be replaced by a period of increased volatility as doubts begin to rise over the sustainability of the highly accommodative policies of both the ECB and BoJ, together with increasing concerns regarding a lack of policy consensus within the FOMC. The net result of which will likely be a reduction in portfolio leverage by asset risk management committees, resulting a larger market swings while adjustments are made. Today, the President of the European Commission, Claude Juncker, will deliver his annual State of the European Union address which could shed some light on likely policy and vision, particularly in the light of Brexit, along with the proposed Italian Referendum, imminent elections in Spain and the US followed next year by Germany and France. While loud calls for a further rate cut are not expected, focus will move rapidly onto Japan, whose two-day central bank policy meeting starting on 20th September will also review the unfavourable effects of negative interest rates. With Fed Funds indicating just a 15% chance of a rate cut taking place this month, US equities were sold off again overnight amid polls showing rising support for Republican presidential contender, Donald Trump. Asian equities largely followed this lead, with the Shanghai Composite the main casualty despite its economic planning committee approving almost RMB200bn in investment projects as Beijing seeks to spur growth through domestic investment. The UK is due to release unemployment figures this morning, while Eurozone Industrial Output data is also expected. No major UK corporates are due to provide earning figures this morning, although smaller companies like Alliance Pharma (APH.L), Chariot Oil & Gas (CHAR.L), Dunelm (DNLM.L), Galliford Try (GFRD.L), Modern Water (MWG.L), Rockhopper Exploration (RKH.L) and Wilmington (WIL.L) are anticipated. Markets will also remain sensitive to further news reports from Iran, regarding its threat to shoot down US surveillance planes flying over its territory and the restarting of exports by the Libyan State Oil Company following recapture of its domestic terminals. The FTSE-100 is seen rising some 20 points in early morning trade. " - Barry Gibb, Research Analyst
08 Aug 16
"Although the overnight markets were firmer across the board, London equities are seen opening very modestly better this morning, with the FTSE-100 seen up just 5 to 10 points in early trade. Friday's strong US jobs data was released during Europe's afternoon trade session at the end of last week, leaving equities today instead to reflect on China's export data that was published on Saturday morning. July exports for the country slid 4.4% from a year earlier, following a decline of 4.8% in June while, in US$ terms, the outcome was below that seen in the same month last year. Being below the consensus expectation of a 3.6% decline, it remains clear that global demand for goods from the world's second largest economy continues to struggle. Countering this, opinions from Board Members regarding last week's BoJ monetary easing appear less critical than the media initially suggested. The country's June's trade surplus, however, expanded by a dramatic 80.1% to Y974.4bn, although this still remained below a number top-end forecasts polled by the Wall Street Journal. It was, nevertheless, enough to spur the Nikkei sharply higher and to drag the regions other principal indices up behind it. Meanwhile, celebrating its jobs data, US confidence rose sufficiently to see both the S&P 500 and the NASDAQ push into new record territory, as investors globally continued their move further into riskier assets. The UK is not expected to release any major macro-economic data today, nor are any large corporates scheduled to report." - Barry Gibb, Research Analyst
08 Jun 16
"Equities in London appear set to open down this morning, with the FTSE-100 losing around 14 points in early trade. Sterling and UK equities appear to have been somewhat spooked by recent opinion polls suggesting the Brexit „leave‟ campaigners are now winning more of the wavering vote as June 23rd approaches. This, together with caution ahead of today‟s industrial production data, which is not expected to show any cause for optimism, leaves investors in a sombre mood. The overnight mood in the US was somewhat better, with the S&P 500 and the Dow industrials squeezing-out modest gains and taking indexes close to fresh highs driven primarily by a rally in the energy sector. By comparison, this morning‟s Asian trade left the main territories down, with China leading the way on poor trade data showing exports declining 4.1% year-onyear, sharply below market consensus. As well as release of the UK industrial production and manufacturing output data, investors should watch for RICS residential house prices this morning; later this afternoon, the US weekly petroleum status report is also due. Among the corporates,J Sainsbury is due to release a trading statement on the market open." - Barry Gibb, Research Analyst
28 Mar 17
ClearStar* (CLSU): Building a background for growth (CORP) | Sound Energy (SOU): TE-8 results (HOLD) | LiDCO* (LID): 2017 should be a transformative year (CORP) | Proteome Sciences* (PRM): FY 2016 in line. Moving towards breakeven (CORP) | Fulcrum (FCRM): Significant market potential, rising margins and a strong balance sheet (BUY) | Mortgage Advice Bureau (MAB1): Strong and growing intellectual property (BUY) | 7digital* (7DIG): Open offer result (CORP)
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
Small Cap Breakfast
28 Mar 17
Path Investments—Publication of prospectus from the Energy Investment Company. Raising £1.4m. Admission due on or around 30 March | Franchise Brands—Schedule 1 detailing £28m reverse takeover of Metro Rod. Admission expected 11 April | Alpha FX Group— Schedule 1 from the foreign exchange provider focused on managing exchange rate risk for UK corporates that trade internationally. Fundraise TBC. Admission expected 7 April. | K3 | Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. | Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Tufton | Oceanic Assets– Offer extended to 9 May to enable investors to complete further due diligence.
Small Cap Breakfast
23 Mar 17
K3 Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march.